Recombinant Human MIP-4 (CCL18) 0 ReviewsSubmit a Review Product Details Catalogue Number: 300-34 Description: MIP-4 is a CC chemokine that is expressed in lymph nodes, lungs, placenta and bone marrow. MIP-4's primary receptor is unknown. MIP-4 chemoattracts lymphocytes, and has been shown to exert activity on both CD4+ and CD8+ T cells. Recombinant Human MIP-4 is a 7.8 kDa protein containing 68 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. Source: E.coli Synonyms: Macrophage Inflammatory Protein-4, CCL18, PARC, DC-CK1, AMAC-1 AA Sequence: QVGTNKELCC LVYTSWQIPQ KFIVDYSETS PQCPKPGVIL LTKRGRQICA DPNKKWVQKY ISDLKLNA Purity: ≥ 98% by SDS-PAGE gel and HPLC analyses. Biological Activity: Not available. Calculated Molecular Weight: 7.8 kDa Accession Number: P55774 Gene ID: 6362 crossreactivity: Bacteria, Human, Human + Mouse, Mouse, References PubMed SDS CoA Search Product Line Country Of Origin: USA Not for human use. Research Interest Chemotaxis Immune System Wound Healing product.subtitle.recentcitations First Author Jiang, X Title CCL18-induced LINC00319 promotes proliferation and metastasis in oral squamous cell carcinoma via the miR-199a-5p/FZD4 axis Citation Cell Death & Disease; 11(9) pg777 PubMed Id 32948745 First Author Darlot, B Title Engineered anti-inflammatory peptides inspired by mapping an evasin-chemokine interaction. Citation The Journal of Biological Chemistry; 295(32) pg10926-10939 PubMed Id 32471866 First Author Lee, A W Title A knottin scaffold directs the CXC-chemokine-binding specificity of tick evasins. Citation The Journal of Biological Chemistry; 294(29) pg11199-11212 PubMed Id 31167786
